News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
FDA Approves Purdue Pharma L.P.'s New Opioid-Based Pain Medicine
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
GLP-1
Lilly Wins Court Battle Against Compounders as Judge Backs FDA: Tirzepatide No Longer in Shortage
May 8, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
May 8, 2025
·
2 min read
·
Tristan Manalac
FDA
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
May 8, 2025
·
4 min read
·
Dan Samorodnitsky
Job Trends
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
May 7, 2025
·
3 min read
·
Angela Gabriel